Pharmaceutical significance of cellulose: A review

Express Polymer Letters

Volumn 2, Issue 11, 2008, Pages 758-778

  Kamel, S ^a   Ali, N ^a   Jahangir, K ^a   Shah, S M ^a   El Gendy, A A ^b  

^a UNIVERSITY OF MALAKAND   (Pakistan)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Biopolymers; Cellulose derivatives; Drug delivery

Indexed keywords

EID: 65449176103     PISSN: 1788618X     EISSN: None     Source Type: Journal    
DOI: 10.3144/expresspolymlett.2008.90     Document Type: Review

References (165)

1. Alderman D. A. A.: Review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. International Journal of Pharmaceutical Technology and Product Manufacture, 5, 1-9 (1984).
2. Heller J.: Use of polymers in controlled release of active agents. in 'Controlled Drug Delivery. Fundamentals and Applications' (eds.: Robinson J. R., Lee V. H. L.) Marcel Dekker, New York, 179-212 (1987).
3. Longer M. A., Robinson J. R.: Sustained-release drug delivery systems. in 'Remington's Pharmaceutical Sciences' (Ed.: Remington J. P.) Mack Publishing, Easton, 1676-1693 (1990).
4. Sandip B. T., Ali R.: Extended-release oral drug delivery technologies: monolithic matrix systems. Methods of Molecular Biology, 437, 217-243 (2008).
5. Liu J., Lin S., Li L., Liu E.: Releases of theophylline from polymer blend hydrogels. International Journal of Pharmaceutics, 298, 117-125 (2005).
6. Prokop A., Kozlov E., Carlesso G., Davidson J. M.: Hydrogel-based colloidal polymeric system for protein and drug delivery: physical and chemical characterization, permeability control and applications. Advances in Polymer Science, 160, 119-173 (2002).
7. Zaikov G. E., Iordanskii A. P., Markin V. S.: Diffusion of electrolytes in polymers. VSP Science Press, Utrecht (1988).
8. George S. C., Thomas S.: Transport phenomena through polymeric system. Progress in Polymer Science, 26, 985-1017 (2001).
9. Lindholm T., Juslin M.: Controlled release tablets 3: Ethylcellulose coats containing surfactant and powdered matter. Pharmaceutical Industry, 44, 937-941 (1982).
10. Rodriguez C. F., Bruneau N., Barra J., Alfonso D., Doelker E.: Hydrophilic cellulose derivatives as drug delivery carriers: Influence of substitution type on the properties of compressed matrix tablets. in 'Handbook of Pharmaceutical Controlled Release Technology' (ed.: Wise D. L.) Marcel Dekker, New York, 1-30 (2000).
11. Lapidus H., Lord N. G.: Drug release from compressed hydrophilic matrices. Journal of Pharmaceutical Sciences, 57, 1292-1301 (1968).
12. Bettini R., Colombo P., Massimo G., Catellani P. L., Vitali T.: Swelling and drug release in hydrogel matrices: Polymer viscosity and matrix porosity effects. The European Journal of Pharmaceutical Sciences, 2, 213-219 (1994).
13. Campos-Aldrete M. E., Villafuerte-Robles L.: Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. European Journal of Pharmaceutics and Biopharmaceutics, 43, 173-178 (1997).
14. Amaral H. M., Lobo S. J. M., Ferreira D. C.: Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets. AAPS Pharmaceutical Science Technology, 2, 14-21 (2001).
15. Ford J. L., Rubinstein M. H., Hogan J. E.: Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl methylcellulose matrices. International Journal of Pharmaceutics, 24, 327-338 (1985).
16. Cheong L. W. S., Heng P. W. S., Wong L. F.: Relationship between polymer viscosity and drug release from a matrix system. Pharmaceutical Research, 9, 1510-1514 (1992).
17. Tahara K., Yamamoto K., Nishihata T.: Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose. Journal of Controlled Release, 35, 59-66 (1995).
18. Krögel I., Bodmeier R.: Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. Journal of Controlled Release, 61, 43-50 (1999).
19. Shah N., Zhang G., Apelian V., Zeng F., Infield M. H., Malick A. W.: Prediction of drug release from hydroxypropyl methylcellulose (HPMC) matrices: Effect of polymer concentration. Pharmaceutical Research, 10, 1693-1695 (1993).
20. Xu G., Sunada H.: Influence of formulation change on drug release kinetics from hydroxypropyl methylcellulose matrix tablets. Chemical and Pharmaceutical Bulletin, 43, 483-487 (1995).
21. Velasco M. V., Ford J. L., Rowe P., Rajabi-Siahboomi A. R.: Influence of drug: Hydroxypropyl methylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. Journal of Controlled Release, 57, 75-85 (1999).
22. Mitchell K., Ford J. L., Armstrong D. J., Elliot P. N. C., Hogan J. E., Rostron C.: The influence of substitution type on the performance of methyl cellulose and hydroxypropyl methylcellulose in gels and matrices. European Journal of Pharmaceutics and Biopharmaceutics, 100, 143-154 (1993).
23. Sheskey P. J., Williams D. M.: Comparison of low-shear and high-shear wet granulation techniques and the influence of percent water addition in the preparation of a controlled-release matrix tablet containing HPMC and a highdose, highly water-soluble drug. Pharmaceutical Technology, 20, 81-92 (1996).
24. Bettini R., Colombo P., Massimo G., Catellani P. L., Vitali T.: Swelling and drug release in hydrogel matrices: Polymer viscosity and matrix porosity effects. The European Journal of Pharmaceutical Sciences, 2, 213-219 (1994).
25. Ford J. L., Rubinstein M. H., Hogan J. E.: Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl methylcellulose matrices. International Journal of Pharmaceutics, 24, 327-338 (1985).
26. Selkirk A. B., Ganderton D.: The influence of wet and dry granulation methods on the pore structure of lactose tablets. Journal of Pharmaceutical and Pharmacology, 22, 86S-94S (1970).
27. Huber H. E., Christenson G. L.: Utilisation of hydrophilic gums for the control of drug substance release from tablet formulations II. Influence of tablet hardness and density on dissolution behavior. Journal of Pharmaceutical Sciences, 57, 164-166 (1968).
28. Genc L., Bilac H., Güler E.: Studies on controlled release dimenhydrinate from matrix tablet formulations. Pharmaceutical Acta Helvetiae, 74, 43-49 (1999).
29. Chalmers A. A., Elworthy P. H.: Oxytetracycline tablet formulations: The influence of excipients and the method of granulation. Journal of Pharmaceutical and Pharmacology, 28, 234-238 (1976).
30. Chowhan Z. T., Yang I-C.: Effect of intergranular versus intragranular corn starch on tablet friability and in vitro dissolution. Journal of Pharmaceutical Sciences, 72, 983-988 (1983).
31. Khattab I., Menon A., Sakr A.: Effect of mode of incorporation of disintegrants on the characteristics of fluid-bed wet-granulated tablets. Journal of Pharmaceutical and Pharmacology, 45, 687-691 (1993).
32. Li J. Z., Rekhi G. S., Augsburger L. L., Shangraw R. F.: The role of intra- and extragranular microcrystalline cellulose in tablet dissolution. Pharmaceutical Development and Technology, 1, 343-355 (1996).
33. Zhang Y. E., Tchao R., Schwartz J. B.: Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release. Pharmaceutical Development and Technology, 6, 131-144 (2001).
34. Hinterstoisser B., Salmen L.: Application of dynamic 2D FTIR to cellulose. Vibrational Spectroscopy, 22, 111-118 (2000).
35. Bochek A. M.: Effect of hydrogen bonding on cellulose solubility in aqueous and nonaqueous solvents. Russian Journal of Applied Chemistry, 76, 1711-1719 (2003).
36. Myasoedova V. V.: Physical chemistry of non-aqueous solutions of cellulose and its derivatives. John Wiley and Sons, Chirchester (2000).
37. Gross R. A., Scholz C.: Biopolymers from polysaccharides and agroproteins. American Chemical Society, Washington (2000).
38. Akira I.: Chemical modification of cellulose. in 'Wood and Cellulosic Chemistry' (eds.: Hon D. N-S., Shiraishi N.) Marcel Dekker, New York, 599-626 (2001).
39. Conner A. H.: Size exclusion chromatography of cellulose and cellulose derivatives. in 'Handbook of Size Exclusion Chromatography' (ed.: Wu C-S.) Marcel Dekker, New York, 331-352 (1995).
40. Sjostrom E.: Wood chemistry, fundamentals and applications. Academic Press, New York (1993).
41. Kuga S., Brown R. M. Jr.: Silver labeling of the reducing ends of bacterial cellulose. Carbohydrate Research, 180, 345-350 (1988).
42. Saxena I. M., Bown R. M.: Cellulose biosynthesis: Current views and evolving concepts. Annals of Botany, 96, 9-21 (2005).
43. Kolpak F. J., Blackwell J.: Determination of the structure of cellulose II. Macromolecules, 9, 273-278 (1976).
44. Langan P., Nishiyama Y., Chanzy H.: A revised structure and hydrogen-bonding system in cellulose II. From a neutron fiber diffraction analysis. Journal of American Chemical Society, 121, 9940-9946 (1999).
45. Wada M., Heux L., Isogai A., Nishiyama Y., Chanzy H., Sugiyama J.: Improved structural data of cellulose IIII prepared in supercritical ammonia. Macromolecules, 34, 1237-1243 (2001).
46. I and its relationship to other cellulose polymorphs. Macromolecules, 9, 857-863 (1976).
47. Chanzy H., Vincendon M., Henrissat B., Tanner S. F., Belton P. S.: Solid state 13C-NMR and electron microscopy study on the reversible transformation cellulose I-cellulose IIII in Valonia. Carbohydrate Research, 160, 1-11 (1987).
48. Buleon A., Chanzy H.: Single crystals of cellulose IVII. Preparation and properties. Journal of Polymer Science: Polymer Physics Edition, 18, 1209-1217 (1980).
49. Klemm D., Heublein B., Fink H-P. Bonn A.: Cellulose: Fascinating biopolymer and sustainable raw material. Angewandte Chemie, International Edition, 44, 3358-3393 (2005).
50. Nabar G. M., Padmanabhan C. V.: Studies in oxycellulose. Proceedings of the Indian Academy of Sciences: A, 31, 371-80 (1950).
51. Da Silva Perez D., Montanari S., Vignon M. R.: TEMPO-mediated oxidation of cellulose III. Biomacromolecules, 4, 1525-1425 (2003).
52. Chang P. S., Robyt J. F.: Oxidation of primary alcohol groups of naturally occurring polysaccharides with 2,2,6,6-tetramethyl-1-piperidine oxoammonium ion. Journal of Carbohydrate Chemistry, 15, 819-830 (1996).
53. Manderson K., Pinart M., Tuohy K. M., Grace W. E., Hotchkiss A. T., Widmer W., Yadhav M. P., Gibson G. R., Rastall R. A.: In vitro determination of prebiotic properties of oligosaccharides derived from an orange juice manufacturing by-product stream. Applied and Environmental Microbiology, 71, 8383-8389 (2005).
54. Kim U-J., Kuga S., Wada M., Okano T., Kondo T.: Periodate oxidation of crystalline cellulose. Biomacromolecules, 1, 488-492 (2000).
55. Bogaard J., Morris H. R., Whitmore P. M.: A method for the aqueous deacidification of oxidized paper. Journal of the American Institute for Conservation, 44, 63-74 (2005).
56. Lichtenthale F. W.: Ullmann's encyclopedia of industrial chemistry. 6th edition: Carbohydrates. Wiley-VCH, Weinheim (2002).
57. Sun Y., Lin L., Deng H., Li J., He B., Sun R., Ouyang P.: Structural changes of bamboo cellulose in formic acid. Bioresources, 3, 297-315 (2008).
58. Reier C. E., Shangraw R. F.: Microcrystalline cellulose in tableting. Journal of Pharmaceutical Sciences, 55, 510-515 (1966).
59. Durand H. W., Fleck E. J., Raynor G. E.: Microcrystalline cellulose compositions Co-dried with hydrocelluloses. US patent 3 537 058, USA (1970).
60. Battista O. A., Smith P. A.: Microcrystalline cellulose. Industrial and Engineering Chemistry, 54, 20-29 (1962).
61. Baruah P. P., Bhattacharya G. C., Chaliha B. P.: Microcrystalline cellulose from cotton. Indian Pulp and Paper, 971-976 (2000).
62. Bhimte N. A., Tayade P. T.: Evaluation of microcrystalline cellulose prepared from sisal fibers as a tablet excipient: A technical note. AAPS Pharmaceutical Science and Technology, 8, 1-6 (2007).
63. Anand S. M., Chawla J. S.: Microcrystalline cellulose from hosiery waste. Research and Industry, 26, 227-235 (1981).
64. Nagavi B. G, Mithal B. M., Chawla J. S.: Microcrystalline cellulose from corncobs. Research Industry, 28, 277-280 (1989).
65. Jain A. K., Dixit V. K., Varma K. C.: Preparation of microcrystalline cellulose from cereal straw and its evaluation as a tablet excipient. Industrial Journal of Pharmaceutical Science, 3, 83-85 (1983).
66. El-Sakhawy M., Hassan M. L.: Physical and mechanical properties of microcrystalline cellulose prepared from agricultural residues. Carbohydrate Polymers, 67, 1-10 (2007).
67. Hakansson H., Ahlgren P.: Acid hydrolysis of some industrial pulps: Effect of hydrolysis. Cellulose, 12, 177-183 (2005).
68. Kaputskii F. N., Gert E. V., Torgashov V. I., Zubets O. V.: Hydrogels for medical applications fabricated by oxidative-hydrolytic modification of cellulose. Fiber Chemistry, 37, 485-489 (2005).
69. Kirk R., Othmer D.: Encyclopedia of chemical technology. John Wiley, New York (1968).
70. Cohen S. G., Haas H. C., Farney L., Valle C. Jr.: Preparation and properties of some ether and ester derivatives of hydroxyethylcellulose. Industrial and Engineering Chemistry, 45, 200-203 (1953).
71. Wadworth L. C., Daponte D.: Cellulose esters. in 'Cellulose Chemistry and its Applications' (eds.: Nevell T. P., Zeronian S. H.) Ellis Horwood, Chichester, 349-362 (1985).
72. Delgado J. N., William A.: Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry. Lippincott-Raven Publishers, Wickford (1998).
73. Banker G. S., Kumar V.: Microfibrillated oxycellulose. US patent 5405953, USA (1995).
74. Kibbe A. H.: Handbook of pharmaceutical excipients: Cellulose, silicified microcrystalline. American Public Health Association, Washington (2000).
75. Luukkonen P., Schaefer T., Hellen J., Juppo A. M., Yliruusi J.: Rheological characterization of microcrystalline cellulose and silicified microcrystalline cellulose wet masses using a mixer torque rheometer. International Journal of Pharmaceutics, 188, 181-192 (1999).
76. Edge S., Steele F., Chen A., Tobyn M., Staniforth J. N.: The mechanical properties of compacts of microcrystalline cellulose and silicified microcrystalline cellulose. International Journal of Pharmaceutics, 200, 67-72 (2000).
77. Van Veen B., Bolhuis G. K., Wu Y. S., Zuurman K., Frijlink H. W.: Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline cellulose. European Journal of Pharmaceutics and Biopharmaceutics, 59, 133-138 (2005).
78. Sherwood B. E., Becker J. W.: A new class of high functionality excipients: Silicified microcrystalline cellulose. Pharmaceutical Technology, 22, 78-88 (1998).
79. Guo M., Augsburger L. L.: Potential application of silicified microcrystalline cellulose in direct-fill formulations for automatic capsule-filling machines. Pharmaceutical Development and Technology, 8, 47-59 (2003).
80. Zografi G., Kontny M. J., Yang A. Y. S., Brenner G. S.: Surface area and water vapor sorption of microcrystalline cellulose. International Journal of Pharmaceutics, 18, 99-116 (1984).
81. Hwang R-C., Peck G. R.: A systematic evaluation of the compression and tablets characteristics of various types of microcrystalline cellulose. Pharmaceutical Technology, 24, 112-132 (2001).
82. Muzíková J., Nováková P.: A study of the properties of compacts from silicified microcrystalline celluloses. Drug Development and Industrial Pharmacy, 33, 775-781 (2007).
83. Siepmann J., Kranz H., Bodmeier R., Peppas N. A.: HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharmaceutical Research, 16, 1748-1756 (1999).
84. Colombo P., Bettini R., Peppas N. A.: Observation of swelling process and diffusion front position during swelling in hydroxypropylmethyl cellulose (HPMC) matrices containing a soluble drug. Journal of Controlled Release, 61, 83-91 (1999).
85. Lowman A. M., Peppas N. A.: Hydrogels. in 'Encyclopedia of Controlled Drug Delivery' (ed.: Mathiowitz E.) Wiley, New York, 397-417 (2000).
86. Le Neel T., Morlet-Renaud C., Lipart C., Gouyette A., Truchaud A., Merle C.: Image analysis as a new technique for the study of water uptake in tablets. STP Pharma Sciences, 7, 117-122 (1997).
87. Baumgartner S., Šmid-Korbar J., Vreèer F., Kristl J.: Physical and technological parameters influencing floating properties of matrix tablets based on cellulose ethers. STP Pharmaceutical Sciences, 8, 182-187 (1998).
88. Arion H.: Carboxymethyl cellulose hydrogel-filled breast implants. Our experience in 15 years (in French). Annales de Chirurgie Plastique et Esthétique, 46, 55-59 (2001).
89. Hercules Incorporated, Aqualon Division: [u http://www.aqualon.com u] (16.07.2008).
90. Sannino A., Madaghiele M., Conversano F., Mele G., Maffezzoli A., Netti P. A., Ambrosio L., Nicolais L.: Cellulose derivative-hyaluronic acid-based microporous hydrogels crosslinked through divinyl sulfone (DVS) to modulate equilibrium sorption capacity and network stability. Biomacromolecules, 5, 92-673 (2004).
91. Valeriani M., Mezzana P., Madonna S., Terracina F.: Carboxy-methyl-cellulose hydrogel mammary implants: Our experience. Acta Chirurgiae Plasticae, 44, 71-76 (2002).
92. Domínguez A., Valdivia A., Hernández J., Villalonga R.: Biocompatibilid in vitro de Superóxido dismutasa interactuando con polímero e hidrogeles de carboximetilcelulosa ensayado con fibroblastos humanos. Revista de Biotecnología Aplicada, 21, 218-2381 (2004).
93. Domínguez A.: Modifying superoxide dismutase for improved biopharmaceutical properties. Biotecnología Aplicada, 23, 17-21 (2006).
94. Klestov A. C., Webb J., Latt D., Schiller G., McNamara K., Young D. Y., Hobbes J., Fetherston J.: Treatment of xerostomia: A double-blind trial in 108 patients with Sjögren's syndrome. Oral Surgery Oral Medicine and Oral Pathology, 51, 594-599 (1981).
95. Olsson H., Axell T.: Objective and subjective efficacy of saliva substitutes containing mucin and carboxymethyl cellulose. Scandinavian Journal of Dental Research, 99, 316-319 (1991).
96. Rokhade A. P., Agnihotri S. A., Patil S. A., Mallikarjuna N. N., Kulkarni P. V., Aminabhavi T. M.: Semiinterpenetrating polymer network microspheres of gelatin and sodium carboxymethyl cellulose for controlled release of ketorolac tromethamine. Carbohydrate Polymers, 65, 243-252 (2006).
97. Flower R. J., Moncada S., Vane J. R.: Indomethacin. in 'Goodman and Gilman's the Pharmacological Basis of Therapeutics' (eds.: Hardman J. G., Limbird L. E.) Macmillan Publishing, New York, 695-697 (1990).
98. Waree T., Garnpimol C. R.: Development of indomethacin sustained release microcapsules using chitosan-carboxymethyl cellulose complex coacervation. Songklanakarin Journal of Science Technology, 25, 245-254 (2003).
99. Ritthidej G. C., Tiyaboonchai W.: Formulation and drug entrapment of microcapsules prepared from chitosan-carboxymethylcellulose complex coacervation. Thai Journal of Pharmaceutical Sciences, 21, 137-144 (1997).
100. Hou W. M., Miyasaki S., Takada M., Komai T.: Sustained release of indomethacin from chitosan granules. Chemical and Pharmaceutical Bulletin, 33, 3986-3992 (1985).
101. Thanoo B. C., Sunny M. C., Jayakrishnan A.: Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for the controlled release of pharmaceuticals. Journal of Pharmacy and Pharmacology, 44, 283-286 (1992).
102. Polk A., Amsden B., De Yao K., Peng T., Goosen M. F.: Controlled release of albumin from chitosan-alginate microcapsules. Journal of Pharmaceutical Sciences, 83, 178-195 (1994).
103. Remunan-Lopez C., Bodmeier R.: Effect of formulation and processing variables on the formation of chitosan-gelatin coacervates. International Journal of Pharmaceutics, 135, 63-72 (1996).
104. Kunal P., Banthia A. K., Majumdar D. K.: Esterification of carboxymethyl cellulose with acrylic acid for targeted drug delivery system. Trends in Biomaterials and Artificial Organs, 19, 12-14 (2005).
105. Kunal P., Banthia A. K., Majumdar D. K.: Development of carboxymethyl cellulose acrylate for various biomedical applications. Biomedical Materials, 1, 85-91 (2006).
106. Wilkes G. M.: Consumers guide to cancer drugs (American Cancer Society). Jones and Bartlett Publishers, Sudbury (2004).
107. Keiji S., Noboru O.: Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chemical and Pharmaceutical Bulletin, 9, 866-872 (1961).
108. Chiou W. L., Riegelman S.: Oral absorption of griseofulvin in dogs. Increased absorption via solid dispersion in polyethylene glycol 6000. Journal of Pharmaceutical Sciences, 59, 937-942 (1970).
109. Sugimoto I., Kuchiki A., Nakagawa H., Tohgo A., Kondo S., Iwane I., Takahashi K.: Dissolution and absorption of nifedipine from nifedipine-polyvinylpyrrolidone coprecipitate. Drug Development and Industrial Pharmacy, 6, 137-160 (1980).
110. Takeuchi H., Handa T., Kawashima Y.: Spherical solid dispersion containing amorphous tolbutamide embedded in enteric coating polymers or colloidal silica prepared by spray-drying technique. Chemical and Pharmaceutical Bulletin, 35, 3800-3806 (1987).
111. Suzuki H., Sunada H.: Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chemical and Pharmaceutical Bulletin, 46, 482-487 (1998).
112. Ozeki T., Yuasa H., Okada H.: Controlled release of drug via methylcellulose-carboxyvinyl polymer interpolymer complex solid dispersion. AAPS Pharmaceutical Science and Technology, 6, 231-236 (2005).
113. Mura P., Faucci M. T., Manderioli A., Bramanti G., Parrini P.: Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersion. Drug Development and Industrial Pharmacy, 25, 257-264 (1999).
114. Friedman M., Golomb G.: New sustained release dosage form of chlorhexidine for dental use. Journal of Periodontal Research, 17, 323-328 (1982).
115. Soskolne W. A., Golomb G., Friedman M., Sela M. N.: New sustained release dosage form of chlorhexidine for dental use. Journal of Periodontal Research, 18, 330-336 (1983).
116. Yuasa H., Ozeki T., Kanaya Y., Oishi K., Oyake T.: Application of the solid dispersion method to the controlled release of medicine. I. Controlled release of water soluble medicine by using solid dispersion. Chemical and Pharmaceutical Bulletin, 39, 465-467 (1991).
117. Yuasa H., Ozeki T., Kanaya Y., Oishi K.: Application of the solid dispersion method to the controlled release of medicine. II. Sustained release tablet using solid dispersion granule and the medicine release mechanism. Chemical and Pharmaceutical Bulletin, 40, 1592-1596 (1992).
118. Ozeki T., Yuasa H., Kanaya Y., Oishi K.: Application of the solid dispersion method to the controlled release of medicine. V. Suppression mechanism of the medicine release rate in the three-component solid dispersion system. Chemical and Pharmaceutical Bulletin, 42, 337-343 (1994).
119. Ozeki T., Yuasa H., Kanaya Y., Oishi K.: Application of the solid dispersion method to the controlled release of medicine. VII. Release mechanism of a highly water-soluble medicine from solid dispersion with different molecular weight of polymer. Chemical and Pharmaceutical Bulletin, 43, 660-665 (1995).
120. Ozeki T., Yuasa H., Kanaya Y., Oishi K.: Application of the solid dispersion method to the controlled release of medicine. VIII. Medicine release and viscosity of the hydrogel of a water-soluble polymer in athree-component solid dispersion system. Chemical and Pharmaceutical Bulletin, 43, 1574-1579 (1995).
121. Yuasa H., Takahashi H., Ozeki T., Kanaya Y., Ueno M.: Application of the solid dispersion method to the controlled release of medicine. III. Control of the release rate of slightly water soluble medicine from solid dispersion granules. Chemical and Pharmaceutical Bulletin, 41, 397-399 (1993).
122. Yuasa H., Ozeki T., Takahashi H., Kanaya Y., Ueno M.: Application of the solid dispersion method to the controlled release of medicine. VI. Release mechanism of slightly water soluble medicine and interaction between flurbiprofen and hydroxypropyl cellulose in solid dispersion. Chemical and Pharmaceutical Bulletin, 42, 354-358 (1994).
123. Ozeki T., Yuasa H., Kanaya Y.: Application of the solid dispersion method to the controlled release of medicine. IX. Difference in the release of flurbiprofen from solid dispersions with poly(ethylene oxide) and hydroxypropylcellulose and interaction between medicine and polymers. International Journal of Pharmaceutics, 115, 209-217 (1997).
124. Nagai T., Machida Y.: Advances in drug delivery: Mucosal adhesive dosage forms. Pharmaceutical International, 6, 196-200 (1985).
125. Satoh K., Takayama K., Machida Y., Suzuki Y., Nakagaki M., Nagai T.: Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. Chemical and Pharmaceutical Bulletin, 37, 1366-1368 (1989).
126. Han R-Y., Fang J-Y., Sung K. C., Hu O. Y. P.: Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: Effect of formulation variables on drug release and mucoadhesive performance. International Journal of Pharmaceutics, 177, 201-209 (1999).
127. Chen W-G., Hwang G. C-C.: Adhesive and in vitro release characteristics of propranolol bioadhesive disc system. International Journal of Pharmaceutics, 82, 61-66 (1992).
128. Park C. R., Munday D. L.: Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. International Journal of Pharmaceutics, 237, 215-226 (2002).
129. Lo Muzio L., Della Valle A., Mignogna M. D., Pannone G., Bucci P., Bucci E., Sciubba J.: The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: A clinical and pilot study on 54 patients. Journal of Oral Pathology and Medicine, 30, 611-617 (2001).
130. Senel S., Hincal A. A.: Drug permeation enhancement via buccal route: Possibilities and limitations. Journal of Controlled Release, 72, 133-144 (2001).
131. Okamoto H., Nakamori T., Arakawa Y., Iida K., Danjo K.: Development of polymer film dosage forms of lidocaine for buccal administration. II. Comparison of preparation methods. Journal of Pharmaceutical Sciences, 91, 2424-2432 (2002).
132. Mizrahi B., Golenser J., Wolnerman J. S., Domb A. J.: Adhesive tablet effective for treating canker sores in humans. Journal of Pharmaceutical Sciences, 93, 2927-2935 (2004).
133. Gurruchaga M., Goñi I., Valero M., Guzmán G. M.: Graft polymerisation of acrylic monomers onto starch fractions. I. Effect of reaction time on grafting MMA onto amylopectin. Journal of Polymer Science, Part A: Polymer Chemistry, 21, 2573-2580 (1983).
134. Gander B., Gurny R., Doelker E., Peppas N. A.: Crosslinked poly(alkylene oxides) for the preparation of controlled release micromatrices. Journal of Controlled Release, 5, 271-283 (1988).
135. Gon M. C., Ferrero R. M., Jimenez C., Gurruchaga M.: Synthesis of hydroxypropyl methacrylate/ polysaccharide graft copolymers as matrices for controlled release tablets. Drug Development and Industrial Pharmacy, 28, 1101-1115 (2002).
136. Tahara K., Yamamoto K., Nishihata T.: Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropylmethyl cellulose. Journal of Controlled Release, 35, 59-66 (1995).
137. Skoug J. W., Mikelsons M. V., Vigneron C. N., Stemm N. L.: Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release. Journal of Controlled Release, 27, 227-245 (1993).
138. Ford J. L., Rubinstein M. H., McCaul F., Hogan J. E., Edgar P. J.: Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethyl cellulose matrix tablets. International Journal of Pharmaceutics, 40, 223-234 (1987).
139. Ranga Rao K V., Padmalatha D., Buri P.: Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices. Journal of Controlled Release, 12, 133-141 (1990).
140. Harland R. S., Gazzaniga A., Sangalli M. E., Colombo P., Peppas N. A.: Drug/polymer matrix swelling and dissolution. Pharmaceutical Research, 5, 488-494 (1988).
141. Lee P. I.: Diffusional release of a solute from a polymeric matrix-approximate analytical solution. Journal of Membrane Science, 7, 255-275 (1980).
142. Lee P. I., Peppas N. A.: Prediction of polymer dissolution in swellable controlled-release systems. Journal of Controlled Release, 6, 207-215 (1987).
143. Reynolds T. D., Gehrke S. H., Hussain A. S., Shenouda S. L.: Polymer erosion and drug release characterization of hydroxypropylmethyl cellulose matrices. Journal of Pharmaceutical Sciences, 87, 1115-1123 (1998).
144. Reynolds T. D., Mitchell S. A., Balwinski K. M.: Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Development and Industrial Pharmacy, 28, 457-466 (2002).
145. Katzhendler I., Mader K., Friedman M.: Structure and hydration properties of hydroxypropyl methylcellulose matrices containing naproxen and naproxen sodium. International Journal of Pharmaceutics, 200, 161-179 (2000).
146. Lee P. I.: Kinetics of drug release from hydrogel matrices. Journal of Controlled Release, 2, 277-288 (1985).
147. Colombo P.: Swelling-controlled release in hydrogel matrices for oral route. Advanced Drug Delivery Reviews, 11, 37-57 (1993).
148. Vazquez M-J., Casalderrey M., Duro R., Gómez-Amoza J-L., Martinez-Pacheco R., Souto C., Concheiro A.: Atenolol release from hydrophilic matrix tablets with hydroxypropylmethylcellulose (HPMC) mixtures as gelling agent: Effects of the viscosity of the HPMC mixture. The European Journal of Pharmaceutical Sciences, 4, 39-48 (1996).
149. Alvarez-Lorenzo C., Duro R., Gomez-Amoza J. L., Martinez-Pacheco R., Souto C., Concheiro A.: Influence of polymer structure on the rheological behavior of hydroxypropylmethylcellulose-sodium carboxymethylcellulose dispersions. Colloid and Polymer Science, 279, 1045-1057 (2001).
150. Khanvilkar K. H., Ye H., Moore A. D.: Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 23 full factorial design. Drug Development and Industrial Pharmacy, 28, 601-608 (2002).
151. Ye H., Khanvilkar K. H., Moore A. D., Hilliard-Lott M.: Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropylmethyl cellulose. Drug Development and Industrial Pharmacy, 29, 79-88 (2003).
152. Liu Z., Li J., Nie S., Liu H., Ding P., Pan W.: Study of an alginate/ HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. International Journal of Pharmaceutics, 315, 12-17 (2006).
153. Suvitayavat W., Tunglert S., Thirawarapan S. S., Bunyapraphatsara N.: Effects of Ya-hom on blood pressure in rats. Journal of Ethnopharmacology, 97, 503-508 (2005).
154. Phaechamu T., Vesapun C., Kraisit P.: Ya Hom in dosage form of buccal tablet. in 'Proceedings of the 10th World Congress on Clinical Nutrition. Phuket, Thailand' 193-198 (2004).
155. Chantana V., Juree C., Thawatchaj P.: Effect of hydroxypropylmethyl cellulose and polyvinyl pyrrolidone on physical properties of Yahom buccal tablets and the antimicrobial activity of Yahom. in 'The 4th Thailand Materials Science Technology Conference. Khong Wan, Thailand' PP01/1-PP01/3 (2006).
156. Lenaerts V., Dumoulin Y., Mateescu M. A.: Controlled release of theophylline from cross-linked amylose tablets. Journal of Controlled Release, 15, 39-46 (1991).
157. Rahmouni M., Lenaerts V., Massuelle D., Doelker E., Johnson M., Leroux J-C.: Characterization of binary mixtures consisting of cross-linked high amylase starch and hydroxypropylmethyl cellulose used in the preparation of controlled release tablets. Pharmaceutical Development and Technology, 8, 335-348 (2003).
158. Rahmouni M., Chouinard F., Nekka F., Lenaerts V., Leroux J-C.: Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac. European Journal of Pharmaceutics and Biopharmaceutics, 51, 191-198 (2001).
159. Chowhan Z. T.: Role of binder in moisture-induced hardness increase in compressed tablets and its effect on in vitro disintegration and dissolution. Journal of Pharmaceutical Sciences, 69, 1-4 (1980).
160. Amaral M. H., Sousa Lobo J. M., Ferreira D. C.: Effect of hydroxypropylmethyl cellulose and hydrogenated castor oil on naproxen release from sustained-release tablets. APS Pharmaceutical Science and Technology, 2, 1-8 (2001).
161. Liu J., Zhang F., McGinity J. W.: Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. European Journal of Pharmaceutics and Biopharmaceutics, 52, 181-190 (2001).
162. Salsa T., Veiga F., Pina M. E.: Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Development and Industrial Pharmacy, 23, 929-938 (1997).
163. Sandip B., Tiwari T., Krishna M., Raveendra Pai M., Pavak R. M., Pasula
164. Molla M. A. K., Shaheen S. M., Rashid M., Hossain A. K. M. M.: Rate controlled release of naproxen from HPMC Based sustained release dosage form, I. Microcapsule compressed tablet and matrices. Dhaka University Journal of Pharmaceutical Sciences, 4, (2005).
165. Vueba M. L., Batista de Carvalho L. A. E., Veiga F., Sousa J. J., Pina M. E.: Influence of cellulose ether mixtures on Ibuprofen release: MC25, HPC and HPMC K100M. Pharmaceutical Development and Technology, 11, 213-228 (2006).